Humanized anti CD-20 as an alternative in chronic management of relapsing thrombotic thrombocytopenic microangiopathy resistant to rituximab due to anti chimeric antibody.

Saved in:
Bibliographic Details
Title: Humanized anti CD-20 as an alternative in chronic management of relapsing thrombotic thrombocytopenic microangiopathy resistant to rituximab due to anti chimeric antibody.
Authors: Ahmadpoor P; Department of Nephrology, Dialysis and Apheresis, University Hospital Caremeau, Nimes, France., Aglae C; Department of Nephrology, Dialysis and Apheresis, University Hospital Caremeau, Nimes, France., Garo F; Department of Nephrology, Dialysis and Apheresis, University Hospital Caremeau, Nimes, France., Cariou S; Department of Nephrology, Dialysis and Apheresis, University Hospital Caremeau, Nimes, France., Renaud S; Department of Nephrology, Dialysis and Apheresis, University Hospital Caremeau, Nimes, France., Reboul P; Department of Nephrology, Dialysis and Apheresis, University Hospital Caremeau, Nimes, France., Moranne O; Department of Nephrology, Dialysis and Apheresis, University Hospital Caremeau, Nimes, France. olivier.moranne@chu-nimes.fr.; Service de Néphrologie, Dialyse, Apherese, Hopital Universitaire Caremeau, 4 place Pr Robert-Debré, Nimes, 3029, France. olivier.moranne@chu-nimes.fr.
Source: International journal of hematology [Int J Hematol] 2021 Mar; Vol. 113 (3), pp. 456-460. Date of Electronic Publication: 2020 Oct 16.
Publication Type: Journal Article
Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1865-3774
DOI:10.1007/s12185-020-03020-7